Cargando…
Inhibition of IRAK 1/4 alleviates colitis by inhibiting TLR 4/NF-κB pathway and protecting the intestinal barrier
Interleukin-1 receptor-associated kinase 1/4 (IRAK1/4) is the main kinase of the toll-like receptor (TLR)-mediated pathway, considered a new target for treating inflammatory diseases. Studies showed a significant correlation between TLRs and inflammatory responses in ulcerative colitis. Therefore, i...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589302/ https://www.ncbi.nlm.nih.gov/pubmed/35699749 http://dx.doi.org/10.17305/bjbms.2022.7348 |
_version_ | 1784814274621734912 |
---|---|
author | Yan, Bo Li, Xiangjie Zhou, Linxiang Qiao, Yuqing Wu, Jing Zha, Lanlan Liu, Peilu Peng, Shuai Wu, Baixin Yu, Xiaoyun Shen, Lei |
author_facet | Yan, Bo Li, Xiangjie Zhou, Linxiang Qiao, Yuqing Wu, Jing Zha, Lanlan Liu, Peilu Peng, Shuai Wu, Baixin Yu, Xiaoyun Shen, Lei |
author_sort | Yan, Bo |
collection | PubMed |
description | Interleukin-1 receptor-associated kinase 1/4 (IRAK1/4) is the main kinase of the toll-like receptor (TLR)-mediated pathway, considered a new target for treating inflammatory diseases. Studies showed a significant correlation between TLRs and inflammatory responses in ulcerative colitis. Therefore, in this study, after inducing experimental colitis in mice with 3% dextran sulfate sodium (DSS), different concentrations of IRAK1/4 inhibitors were administered intraperitoneally. Then, the disease activity index was assessed, including the degree of pathological damage, by HE staining. Subsequently, while Western blotting detected the TLR4/NF-κB pathway and intestinal barrier protein expression (Zonula-1, Occludin, Claudin-1, JAM-A), real-time polymerase chain reaction detected the mRNA expression levels of IRAK1/4 and mucin1/2. Furthermore, the expression levels of Zonula-1 and occludin were detected by immunofluorescence, including the plasma FITC-dextran 4000 concentration, to evaluate intestinal barrier permeability. However, ELISA measured the expression of inflammatory factors to reflect intestinal inflammation in mice. Investigations showed that the IRAK 1/4 inhibitor significantly reduced clinical symptoms and pathological DSS-induced colitis damage in mice and then inhibited the cytoplasmic and nuclear translocation of NF-κB p65, including the phosphorylation of IκBα and reduction in downstream inflammatory factor production. Therefore, we established that the IRAK1/4 inhibitor effectively improves colitis induced by DSS, partly by inhibiting the TLR4/NF-κB pathway, reducing inflammation, and maintaining the integrity of the colonic barrier. |
format | Online Article Text |
id | pubmed-9589302 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina |
record_format | MEDLINE/PubMed |
spelling | pubmed-95893022022-12-01 Inhibition of IRAK 1/4 alleviates colitis by inhibiting TLR 4/NF-κB pathway and protecting the intestinal barrier Yan, Bo Li, Xiangjie Zhou, Linxiang Qiao, Yuqing Wu, Jing Zha, Lanlan Liu, Peilu Peng, Shuai Wu, Baixin Yu, Xiaoyun Shen, Lei Bosn J Basic Med Sci Research Article Interleukin-1 receptor-associated kinase 1/4 (IRAK1/4) is the main kinase of the toll-like receptor (TLR)-mediated pathway, considered a new target for treating inflammatory diseases. Studies showed a significant correlation between TLRs and inflammatory responses in ulcerative colitis. Therefore, in this study, after inducing experimental colitis in mice with 3% dextran sulfate sodium (DSS), different concentrations of IRAK1/4 inhibitors were administered intraperitoneally. Then, the disease activity index was assessed, including the degree of pathological damage, by HE staining. Subsequently, while Western blotting detected the TLR4/NF-κB pathway and intestinal barrier protein expression (Zonula-1, Occludin, Claudin-1, JAM-A), real-time polymerase chain reaction detected the mRNA expression levels of IRAK1/4 and mucin1/2. Furthermore, the expression levels of Zonula-1 and occludin were detected by immunofluorescence, including the plasma FITC-dextran 4000 concentration, to evaluate intestinal barrier permeability. However, ELISA measured the expression of inflammatory factors to reflect intestinal inflammation in mice. Investigations showed that the IRAK 1/4 inhibitor significantly reduced clinical symptoms and pathological DSS-induced colitis damage in mice and then inhibited the cytoplasmic and nuclear translocation of NF-κB p65, including the phosphorylation of IκBα and reduction in downstream inflammatory factor production. Therefore, we established that the IRAK1/4 inhibitor effectively improves colitis induced by DSS, partly by inhibiting the TLR4/NF-κB pathway, reducing inflammation, and maintaining the integrity of the colonic barrier. Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2022-12 2022-06-14 /pmc/articles/PMC9589302/ /pubmed/35699749 http://dx.doi.org/10.17305/bjbms.2022.7348 Text en Copyright: © The Author(s) (2022) https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License |
spellingShingle | Research Article Yan, Bo Li, Xiangjie Zhou, Linxiang Qiao, Yuqing Wu, Jing Zha, Lanlan Liu, Peilu Peng, Shuai Wu, Baixin Yu, Xiaoyun Shen, Lei Inhibition of IRAK 1/4 alleviates colitis by inhibiting TLR 4/NF-κB pathway and protecting the intestinal barrier |
title | Inhibition of IRAK 1/4 alleviates colitis by inhibiting TLR 4/NF-κB pathway and protecting the intestinal barrier |
title_full | Inhibition of IRAK 1/4 alleviates colitis by inhibiting TLR 4/NF-κB pathway and protecting the intestinal barrier |
title_fullStr | Inhibition of IRAK 1/4 alleviates colitis by inhibiting TLR 4/NF-κB pathway and protecting the intestinal barrier |
title_full_unstemmed | Inhibition of IRAK 1/4 alleviates colitis by inhibiting TLR 4/NF-κB pathway and protecting the intestinal barrier |
title_short | Inhibition of IRAK 1/4 alleviates colitis by inhibiting TLR 4/NF-κB pathway and protecting the intestinal barrier |
title_sort | inhibition of irak 1/4 alleviates colitis by inhibiting tlr 4/nf-κb pathway and protecting the intestinal barrier |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589302/ https://www.ncbi.nlm.nih.gov/pubmed/35699749 http://dx.doi.org/10.17305/bjbms.2022.7348 |
work_keys_str_mv | AT yanbo inhibitionofirak14alleviatescolitisbyinhibitingtlr4nfkbpathwayandprotectingtheintestinalbarrier AT lixiangjie inhibitionofirak14alleviatescolitisbyinhibitingtlr4nfkbpathwayandprotectingtheintestinalbarrier AT zhoulinxiang inhibitionofirak14alleviatescolitisbyinhibitingtlr4nfkbpathwayandprotectingtheintestinalbarrier AT qiaoyuqing inhibitionofirak14alleviatescolitisbyinhibitingtlr4nfkbpathwayandprotectingtheintestinalbarrier AT wujing inhibitionofirak14alleviatescolitisbyinhibitingtlr4nfkbpathwayandprotectingtheintestinalbarrier AT zhalanlan inhibitionofirak14alleviatescolitisbyinhibitingtlr4nfkbpathwayandprotectingtheintestinalbarrier AT liupeilu inhibitionofirak14alleviatescolitisbyinhibitingtlr4nfkbpathwayandprotectingtheintestinalbarrier AT pengshuai inhibitionofirak14alleviatescolitisbyinhibitingtlr4nfkbpathwayandprotectingtheintestinalbarrier AT wubaixin inhibitionofirak14alleviatescolitisbyinhibitingtlr4nfkbpathwayandprotectingtheintestinalbarrier AT yuxiaoyun inhibitionofirak14alleviatescolitisbyinhibitingtlr4nfkbpathwayandprotectingtheintestinalbarrier AT shenlei inhibitionofirak14alleviatescolitisbyinhibitingtlr4nfkbpathwayandprotectingtheintestinalbarrier |